Avidity Partners Management LP lifted its position in Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Free Report) by 12.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,500,328 shares of the company’s stock after buying an additional 718,478 shares during the quarter. Fusion Pharmaceuticals […]
Fusion Pharmaceuticals (NASDAQ:FUSN) Sees Large Volume Increase dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Fusion Pharmaceuticals (NASDAQ:FUSN – Get Free Report) and Aura Biosciences (NASDAQ:AURA – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership. Risk & Volatility Fusion Pharmaceuticals has a […]
Shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) have earned a consensus rating of “Hold” from the fourteen analysts that are presently covering the firm, MarketBeat reports. Thirteen equities research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12 month […]
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Consensus Recommendation of "Hold" by Brokerages etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.